Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 Plus Radiation Therapy for Hepatic Metastases From Colorectal Cancer
NCT03223779Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2017
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in colorectal cancer (CRC), sponsored by Massachusetts General Hospital. Started Oct 2017; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03223779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223779.